AR089728A1 - SALES Y FORMAS CRISTALINAS DE DIHIDROPIRROLO[1,2-c]IMIDAZOLIL COMO INHIBIDOR DE ALDOSTERONA SINTASA O AROMATASA - Google Patents
SALES Y FORMAS CRISTALINAS DE DIHIDROPIRROLO[1,2-c]IMIDAZOLIL COMO INHIBIDOR DE ALDOSTERONA SINTASA O AROMATASAInfo
- Publication number
- AR089728A1 AR089728A1 ARP130100119A ARP130100119A AR089728A1 AR 089728 A1 AR089728 A1 AR 089728A1 AR P130100119 A ARP130100119 A AR P130100119A AR P130100119 A ARP130100119 A AR P130100119A AR 089728 A1 AR089728 A1 AR 089728A1
- Authority
- AR
- Argentina
- Prior art keywords
- aromatase
- forms
- aldosterone
- salts
- dihydropirrolo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
Abstract
Se refiere a una sal de fosfato o una sal de nitrato de 4-(R)-6,7-dihidro-5H-pirrolo[1,2-c]imidazol-5-il-3-fluoro-benzonitrilo, especialmente en forma cristalina, y formas específicas de estas sales, así como a formas de realización. Las sales y formas cristalinas de sales permiten el tratamiento profiláctico y/o terapéutico de enfermedades o trastornos mediados por aldosterona sintasa y/o aromatasa.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261587280P | 2012-01-17 | 2012-01-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR089728A1 true AR089728A1 (es) | 2014-09-10 |
Family
ID=47604250
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP130100119A AR089728A1 (es) | 2012-01-17 | 2013-01-15 | SALES Y FORMAS CRISTALINAS DE DIHIDROPIRROLO[1,2-c]IMIDAZOLIL COMO INHIBIDOR DE ALDOSTERONA SINTASA O AROMATASA |
Country Status (41)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102711916B (zh) * | 2010-01-14 | 2015-09-02 | 诺华股份有限公司 | 肾上腺激素调节剂的用途 |
| EP2815749A1 (en) | 2013-06-20 | 2014-12-24 | IP Gesellschaft für Management mbH | Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern |
| JP6731136B2 (ja) | 2014-07-07 | 2020-07-29 | レコルダティ アーゲー | 医薬製剤 |
| MX2017009839A (es) | 2015-01-29 | 2017-11-02 | Novartis Ag | Proceso para la produccion de derivados de imidazolo condensados. |
| US20160287565A1 (en) * | 2015-04-06 | 2016-10-06 | Millendo Therapeutics, Inc. | Combination therapy for treating disorders associated with excess cortisol production |
| WO2018078049A1 (en) * | 2016-10-27 | 2018-05-03 | Damian Pharma Ag | Aldosterone synthase inhibitor |
| EP3532056A1 (en) * | 2016-10-27 | 2019-09-04 | Damian Pharma AG | Aldosterone synthase inhibitor |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1315449A (en) * | 1918-11-15 | 1919-09-09 | Frank B Yingling | Shaper-feed. |
| US4617307A (en) * | 1984-06-20 | 1986-10-14 | Ciba-Geigy Corporation | Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors |
| US5066656A (en) | 1989-11-01 | 1991-11-19 | Janssen Pharmaceutica N.V. | Pharmacologically active (6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives |
| MTP1076B (en) | 1990-01-12 | 1991-09-30 | Ciba Geigy Ag | Hemihydrate |
| DE69330557T2 (de) | 1992-01-27 | 2002-06-20 | Janssen Pharmaceutica Nv | Pyrroloimidazolyl und imidazopyridinyl substituierte 1h-benzimidazolderivate als aromatase inhibitoren |
| US7223866B2 (en) | 2002-11-18 | 2007-05-29 | Novartis Ag | Imidazo[1,5-a]pyridine derivatives and methods for treating aldosterone mediated diseases |
| GT200600381A (es) | 2005-08-25 | 2007-03-28 | Compuestos organicos | |
| WO2008076862A2 (en) | 2006-12-18 | 2008-06-26 | Novartis Ag | 1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors |
| WO2011064376A1 (en) | 2009-11-30 | 2011-06-03 | Novartis Ag | Imidazole derivatives as aldosterone synthase inhibitors |
| CN102711916B (zh) * | 2010-01-14 | 2015-09-02 | 诺华股份有限公司 | 肾上腺激素调节剂的用途 |
-
2013
- 2013-01-15 SG SG11201404061YA patent/SG11201404061YA/en unknown
- 2013-01-15 AR ARP130100119A patent/AR089728A1/es unknown
- 2013-01-15 RS RS20160109A patent/RS54589B1/en unknown
- 2013-01-15 EP EP13701194.6A patent/EP2804863B1/en active Active
- 2013-01-15 US US14/370,124 patent/US9334276B2/en active Active
- 2013-01-15 WO PCT/US2013/021521 patent/WO2013109514A1/en active Application Filing
- 2013-01-15 MX MX2014008686A patent/MX2014008686A/es unknown
- 2013-01-15 ES ES13701194.6T patent/ES2564143T3/es active Active
- 2013-01-15 TW TW102101537A patent/TWI609869B/zh not_active IP Right Cessation
- 2013-01-15 SI SI201330142A patent/SI2804863T1/sl unknown
- 2013-01-15 BR BR112014017260A patent/BR112014017260A8/pt not_active Application Discontinuation
- 2013-01-15 CN CN201380005054.0A patent/CN104039793B/zh active Active
- 2013-01-15 IN IN6781DEN2014 patent/IN2014DN06781A/en unknown
- 2013-01-15 JO JOP/2013/0014A patent/JO3137B1/ar active
- 2013-01-15 AP AP2014007762A patent/AP2014007762A0/xx unknown
- 2013-01-15 CA CA2863339A patent/CA2863339C/en active Active
- 2013-01-15 UY UY0001034576A patent/UY34576A/es not_active Application Discontinuation
- 2013-01-15 HU HUE13701194A patent/HUE026984T2/en unknown
- 2013-01-15 UA UAA201406492A patent/UA114803C2/uk unknown
- 2013-01-15 EA EA201491374A patent/EA026232B1/ru not_active IP Right Cessation
- 2013-01-15 DK DK13701194.6T patent/DK2804863T3/en active
- 2013-01-15 PL PL13701194T patent/PL2804863T3/pl unknown
- 2013-01-15 JP JP2014552375A patent/JP5749410B2/ja active Active
- 2013-01-15 KR KR20147030158A patent/KR20140141687A/ko not_active Application Discontinuation
- 2013-01-15 AU AU2013209952A patent/AU2013209952B2/en active Active
- 2013-01-15 NZ NZ626277A patent/NZ626277A/en not_active IP Right Cessation
- 2013-01-15 KR KR1020147016954A patent/KR20140093726A/ko not_active Application Discontinuation
- 2013-01-15 PE PE2014001112A patent/PE20142358A1/es not_active Application Discontinuation
-
2014
- 2014-06-11 ZA ZA2014/04314A patent/ZA201404314B/en unknown
- 2014-06-12 TN TNP2014000256A patent/TN2014000256A1/en unknown
- 2014-07-07 IL IL233541A patent/IL233541B/en active IP Right Grant
- 2014-07-08 CO CO14146898A patent/CO7000775A2/es unknown
- 2014-07-11 MA MA37199A patent/MA35858B1/fr unknown
- 2014-07-15 CL CL2014001863A patent/CL2014001863A1/es unknown
- 2014-07-15 CU CU2014000086A patent/CU20140086A7/es unknown
- 2014-07-17 CR CR20140345A patent/CR20140345A/es unknown
- 2014-07-17 GT GT201400155A patent/GT201400155A/es unknown
- 2014-07-17 PH PH12014501638A patent/PH12014501638A1/en unknown
- 2014-11-28 HK HK14112037.4A patent/HK1198536A1/xx unknown
-
2016
- 2016-02-09 US US15/018,953 patent/US20160176883A1/en not_active Abandoned
- 2016-02-19 HR HRP20160178T patent/HRP20160178T1/hr unknown
- 2016-02-26 CY CY20161100163T patent/CY1117914T1/el unknown
- 2016-03-23 SM SM201600083T patent/SMT201600083B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR089728A1 (es) | SALES Y FORMAS CRISTALINAS DE DIHIDROPIRROLO[1,2-c]IMIDAZOLIL COMO INHIBIDOR DE ALDOSTERONA SINTASA O AROMATASA | |
| UY33985A (es) | Sales de 2,3-dihidroimidazo [1,2-c] quinazolina sustituida | |
| ECSP14013224A (es) | Pirimidinas anilladas sustituidas y uso de las mismas | |
| NZ758528A (en) | Bicyclic heterocycle compounds and their uses in therapy | |
| DK3418281T3 (da) | Pyrazolo[1,5-a]pyrimidiner, der er anvendelige som inhibitorer af atr-kinase til behandling af cancersygdomme | |
| CO6930363A2 (es) | Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas | |
| TR201901886T4 (tr) | DNA-PK inhibitörleri. | |
| NZ626937A (en) | Fused tetra or penta-cyclic pyridophthalazinones as parp inhibitors | |
| DOP2013000211A (es) | Ciclopropilaminas como inhibidores de desmetilasa 1 especifica de lisina | |
| CR20130464A (es) | Inhibidores sustituidos de acetil-coa carboxilasa | |
| CY1117543T1 (el) | Αναστολεις βητα-σεκρετασης | |
| UY33314A (es) | Derivados de acido 1-amino-2-ciclopropiletilboronico | |
| ECSP14026138A (es) | Uracilos sustituidos bicíclicamente y uso de los mismos | |
| AR086586A1 (es) | Forma cristalina de ciclosporina a, metodos de preparacion y metodos para utilizar la misma | |
| HRP20182021T1 (hr) | Derivati [1,2,4]triazolo[1,5-a]pirimidina kao inhibitori proteazoma protozoe za liječenje parazitskih bolesti poput lišmenijaze | |
| WO2012104823A3 (en) | Pyridopyrimidinone compounds in the treatment of neurodegenerative diseases | |
| UY34902A (es) | Forma cristalina de un derivado de indolinona y su uso | |
| MX340536B (es) | Terapia direccionada al receptor del factor de crecimiento epidermico (egfr). | |
| PL2726470T3 (pl) | Pochodne 1,2,4-tiadiazol-5-ilo piperazyny przydatne w leczeniu chorób neurodegeneracyjnych | |
| PE20150674A1 (es) | Azaheterociclos como inhibidores de bir2 y/o bir3 | |
| ITRM20120530A1 (it) | Compounds for use in the treatment of parasitic diseases | |
| UA111520C2 (uk) | [1,2,4]триазолопіридини і їх застосування як інгібіторів фосфодіестерази | |
| EP3021944A4 (en) | Igf-1r signaling pathway inhibitors useful in the treatment of neurodegenerative diseases | |
| WO2013050798A3 (en) | Use of photocleavable compounds | |
| TH152473A (th) | รูปแบบใหม่และเกลือของไดไฮโดรไพร์โรโล[1,2-c] อิมิดาโซลิลที่เป็นสารยับยั้งอัลโดสเตอโรนซินเธสหรืออะโรมาเตส |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |